1. Home
  2. TSBK vs DCTH Comparison

TSBK vs DCTH Comparison

Compare TSBK & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Timberland Bancorp Inc.

TSBK

Timberland Bancorp Inc.

HOLD

Current Price

$41.00

Market Cap

310.0M

Sector

Finance

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$11.10

Market Cap

363.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSBK
DCTH
Founded
1915
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
310.0M
363.5M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
TSBK
DCTH
Price
$41.00
$11.10
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$22.00
AVG Volume (30 Days)
18.2K
401.5K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.87%
N/A
EPS Growth
21.93
107.53
EPS
1.94
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
N/A
$33.15
P/E Ratio
$21.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.30
$8.12
52 Week High
$43.55
$17.34

Technical Indicators

Market Signals
Indicator
TSBK
DCTH
Relative Strength Index (RSI) 49.19 52.26
Support Level $39.81 $10.22
Resistance Level $42.40 $11.24
Average True Range (ATR) 0.99 0.58
MACD -0.00 -0.06
Stochastic Oscillator 53.16 25.32

Price Performance

Historical Comparison
TSBK
DCTH

About TSBK Timberland Bancorp Inc.

Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: